ASPN — Aspen Aerogels Income Statement
0.000.00%
- $273.32m
- $235.79m
- $271.10m
Annual income statement for Aspen Aerogels, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 122 | 180 | 239 | 453 | 271 |
| Cost of Revenue | |||||
| Gross Profit | 9.94 | 4.98 | 56.9 | 183 | 46 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 158 | 260 | 288 | 426 | 649 |
| Operating Profit | -36.9 | -79.2 | -49.2 | 27 | -378 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -37.1 | -82.7 | -45.8 | 15.1 | -387 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -37.1 | -82.7 | -45.8 | 13.4 | -390 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -37.1 | -82.7 | -45.8 | 13.4 | -390 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -37.1 | -82.7 | -45.8 | 13.4 | -390 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.34 | -2.1 | -0.66 | 0.509 | -2.15 |